The impact of chronic hepatitis C and co-morbid illnesses on health-related quality of life

Overview of attention for article published in Quality of Life Research, April 2008

Altmetric Badge

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 48 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Simeprevir in combination with peginterferon alfa and ribavirin for treating genotypes 1 and 4 chronic hepatitis C: Hepatitis C (chronic) - simeprevir [ID668]: evaluation report

Cited by National Institute for Health and Care Excellence on 17 Sep 2014

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Sofosbuvir for treating chronic hepatitis C: Hepatitis C (chronic) - sofosbuvir: evaluation report

Cited by National Institute for Health and Care Excellence on 16 Jun 2014

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.